• Updated FECPlus FIXML 5.0 Production Deployment Date: April 22, 2013

      • To
      • Clearing Member Firms; Back Office Managers; Service Providers
      • From
      • CME Clearing
      • #
      • 13-085
      • Notice Date
      • 19 February 2013
      • Effective Date
      • 19 February 2013
    • CME Clearing would like to announce that the FECPlus launch date, including the migration to the FIXML 5.0 API is rescheduled for Monday, April 22, 2013.
       
      REMINDER: Testing for ALL post-trade processing, including give-ups, average-priced give-ups, and cross-exchange allocations, using the FPL-compliant FIXML 5.0 API, is currently available in New Release for CME/CBT/NYMEX/COMEX/DME.
       
      This includes both outbound and inbound messaging capabilities. FECPlus in New Release is used to manage all post-trade processing transactions. The existing FIXML 4.4 API is not used for any post-trade processing in New Release.
       
      We strongly encourage that testing continue at the same pace leading up to the Production launch.
       
      CME Clearing published a test script for testing Post-Trade Processing on FECPlus (see CH Advisory #12-532). Firms should use this high-level test script, in addition to their own test scenarios, to verify their readiness for the Production Launch.
       
      Firm user training for FECPlus will be offered by the Clearing House beginning next week. The schedule for the on-site trainings will be published soon.
       
      CME Clearing will continue to check in periodically with firms on their testing status and to offer assistance with testing.
       
       
      For questions or further information please contact CME Clearing Services (CCS) at 312-207-2525 or ccs@cmegroup.com.

      Printer Friendly Version...

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.